Status:
UNKNOWN
Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of CTC
Lead Sponsor:
Fudan University
Conditions:
Colorectal Cancer
Circulating Tumor Cell
Eligibility:
All Genders
18-80 years
Brief Summary
Detecting circulating tumor cells from I-IV stage colorectal cancer patients pre-and post-operatively. Analyzing the morphology and biomarkers of CTCs and builting prognosis predicting model based on ...
Eligibility Criteria
Inclusion
- Age 18-80 years;
- Histologically proven colorectal carcinoma (TNM stage I-IV)
- R0 resection is possible according to preoperative evaluation
- Written informed consent for participation in the trial.
Exclusion
- Primary tumor or metastases not able to be removed radically
- Receiving any preoperative treatment (Including chemotherapy, radiotherapy and target therapy)
- Have other malignant tumors meanwhile
- Other previous malignancy within 5 years
Key Trial Info
Start Date :
June 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04912882
Start Date
June 15 2021
End Date
December 1 2025
Last Update
June 3 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.